PriceTargets.com logo

Spectral AI - MDAI Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $4.50
  • Forecasted Upside: 138.10%
  • Number of Analysts: 4
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 3 Buy Ratings
  • 1 Strong Buy Ratings
$1.89 As of 12/20/2024 06:40 PM ET
▲ +0.01 (0.53%)

This chart shows the closing price for MDAI by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Spectral AI Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MDAI and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MDAI

Analyst Price Target is $4.50
▲ +138.10% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for Spectral AI in the last 3 months. The average price target is $4.50, with a high forecast of $6.00 and a low forecast of $3.50. The average price target represents a 138.10% upside from the last price of $1.89.

This chart shows the closing price for MDAI for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 4 contributing investment analysts is to buy stock in Spectral AI.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/1/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/29/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/28/2023
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/27/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/25/2024
  • 1 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/23/2024
  • 1 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/22/2024
  • 1 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/22/2024

Latest Recommendations

  • 1 strong buy ratings
  • 3 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
8/13/2024HC WainwrightReiterated RatingBuy ➝ Buy$3.50 ➝ $3.50
8/12/2024Northland CapmkUpgradeStrong-Buy
8/12/2024Northland SecuritiesInitiated CoverageOutperform$6.00
7/18/2024HC WainwrightInitiated CoverageBuy$3.50
1/23/2024BTIG ResearchInitiated CoverageBuy$4.00
(Data available from 12/22/2019 forward)

News Sentiment Rating

0.41 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 4 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/26/2024
  • 4 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/25/2024
  • 6 very positive mentions
  • 7 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
7/25/2024
  • 4 very positive mentions
  • 9 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/24/2024
  • 5 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/23/2024
  • 3 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/23/2024
  • 5 very positive mentions
  • 8 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
11/22/2024
  • 1 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/22/2024

Current Sentiment

  • 1 very positive mentions
  • 10 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Spectral AI logo
Spectral AI, Inc., an artificial intelligence (AI) company, focuses on developing predictive medical diagnostics in the United States. The company develops medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView System, a predictive analytics platform integrated with the predictive AI-Burn, which combines AI algorithms and multispectral imaging (MSI) imaging for an assessment of wound healing potential and offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention; and DeepView SnapShot M, a handheld, portable, and wireless diagnostic tool, that provides a potential enhanced and expanded use for the government and emergency care, first responders, and potentially home health care professionals. The company is headquartered in Dallas, Texas.
Read More

Today's Range

Now: $1.89
Low: $1.78
High: $1.96

50 Day Range

MA: $1.56
Low: $1.06
High: $2.20

52 Week Range

Now: $1.89
Low: $0.82
High: $3.72

Volume

608,579 shs

Average Volume

1,172,008 shs

Market Capitalization

$35.13 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.64

Frequently Asked Questions

What sell-side analysts currently cover shares of Spectral AI?

The following Wall Street analysts have issued stock ratings on Spectral AI in the last twelve months: BTIG Research, HC Wainwright, Northland Capmk, and Northland Securities.
View the latest analyst ratings for MDAI.

What is the current price target for Spectral AI?

0 Wall Street analysts have set twelve-month price targets for Spectral AI in the last year. Their average twelve-month price target is $4.50, suggesting a possible upside of 138.1%. Northland Securities has the highest price target set, predicting MDAI will reach $6.00 in the next twelve months. HC Wainwright has the lowest price target set, forecasting a price of $3.50 for Spectral AI in the next year.
View the latest price targets for MDAI.

What is the current consensus analyst rating for Spectral AI?

Spectral AI currently has 3 buy ratings and 1 strong buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe MDAI will outperform the market and that investors should add to their positions of Spectral AI.
View the latest ratings for MDAI.

What other companies compete with Spectral AI?

Other companies that are similar to Spectral AI include Sensus Healthcare, Jin Medical International, TriSalus Life Sciences, TELA Bio and Fractyl Health. Learn More about companies similar to Spectral AI.

How do I contact Spectral AI's investor relations team?

Spectral AI's physical mailing address is 767 5th Avenue 34th Floor, New York NY, 10153. The company's listed phone number is 212-492-3000 and its investor relations email address is [email protected]. The official website for Spectral AI is rosecliffspac.com. Learn More about contacing Spectral AI investor relations.